Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
This study has been withdrawn prior to enrollment.
University of Medicine and Dentistry of New Jersey
First Posted: July 13, 2005
Last Update Posted: May 27, 2015
National Cancer Institute (NCI)
Information provided by:
Rutgers, The State University of New Jersey
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||July 2005|
|Primary Completion Date:||July 2005 (Final data collection date for primary outcome measure)|